See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Firm says it didn't go public after all

A biotech firm hit the market and traded for only six days, only to announce Friday that it wasn’t issuing shares after all. Vascular Biogenics blamed a key investor’s failure to follow through on a commitment to buy stock. http://online.wsj.com/articles/vascular-biogenics-says-it-didnt-go-public-after-all-1407799783?mod=WSJ_hp_LEFTWhatsNewsCollection

UP NEXT

More from